Rolistobart
Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. Rolistobart is an immunostimulant and antineoplastic[1].
Product Specifications
CAS Number
[2723442-10-0]
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rolistobart.html
Purity
97.78
Solubility
10 mM in DMSO
Smiles
[Rolistobart]
Molecular Weight
(146.62 kDa)
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 36, No. 4, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL516602V 500 µL Each
Zeb2 Mouse shRNA Lentiviral Particle (Locus ID 24136)
Sign In for Pricing
View Details 
K2177307 1.0 µg DNA
SLC25A12 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
M2690-10A-01 50 µg
MCAF (MCP-1, Macrophage/Monocyte Chemotactic and Activating Factor) discontinued
Sign In for Pricing
View Details 
M2690-10A-02 100 µg
MCAF (MCP-1, Macrophage/Monocyte Chemotactic and Activating Factor) discontinued
Sign In for Pricing
View Details